We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+25.19%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.52B
AUM Growth
+$762M
Cap. Flow
+$251M
Cap. Flow %
5.54%
Top 10 Hldgs %
32.69%
Holding
126
New
33
Increased
18
Reduced
34
Closed
36

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$104M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$86M
3
AGN
Allergan plc
AGN
+$83.3M
4
PFE icon
Pfizer
PFE
+$80.2M
5
PBYI icon
Puma Biotechnology
PBYI
+$79.5M

Top Sells

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$145M
2
ABT icon
Abbott
ABT
+$82.8M
3
GDDY icon
GoDaddy
GDDY
+$79.9M
4
AERI
Aerie Pharmaceuticals
AERI
+$68.4M
5
BLK icon
Blackrock
BLK
+$65.5M

Sector Composition

Rank Sector Weight
1 Healthcare 54.61%
2 Technology 11.18%
3 Communication Services 3.96%
4 Consumer Discretionary 3.1%
5 Financials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$469B
$366M 8.08%
+2,035,700
New +$345M
QCOM icon
2
CALL
Qualcomm
QCOM
$185B
$187M 4.13%
+3,278,600
New +$177M
ARNA
3
DELISTED
Arena Pharmaceuticals Inc
ARNA
$146M 3.23%
3,255,230
+240,558
+8% +$11M
ZBH icon
4
Zimmer Biomet
ZBH
$17.2B
$121M 2.68%
979,783
+281,105
+40% +$31.9M
PFE icon
5
Pfizer
PFE
$141B
$120M 2.66%
2,986,083
+2,002,189
+203% +$80.2M
SYK icon
6
Stryker
SYK
$119B
$114M 2.53%
+579,444
New +$104M
UNH icon
7
UnitedHealth
UNH
$392B
$112M 2.47%
451,689
+210,804
+88% +$53.8M
PEN icon
8
Penumbra
PEN
$12.4B
$107M 2.36%
727,057
-175,841
-19% -$25.1M
HUM icon
9
CALL
Humana
HUM
$47.7B
$105M 2.31%
+393,100
New +$113M
PBYI icon
10
Puma Biotechnology
PBYI
$401M
$101M 2.23%
+2,603,920
New +$79.5M
ELV icon
11
Elevance Health
ELV
$84.4B
$99.4M 2.2%
346,397
-105,024
-23% -$30.4M
HUM icon
12
Humana
HUM
$47.7B
$97M 2.14%
364,473
-43,620
-11% -$12.6M
WCG
13
DELISTED
Wellcare Health Plans, Inc.
WCG
$89.8M 1.98%
+332,834
New +$86M
ICUI icon
14
ICU Medical
ICUI
$3.93B
$89.7M 1.98%
374,860
+199,102
+113% +$47.7M
MCHP icon
15
Microchip Technology
MCHP
$46.2B
$85.2M 1.88%
2,053,642
-11,342
-0.5% -$470K
WCG
16
CALL
DELISTED
Wellcare Health Plans, Inc.
WCG
$84.8M 1.87%
+314,500
New +$81.2M
AGN
17
DELISTED
Allergan plc
AGN
$84.2M 1.86%
+574,837
New +$83.3M
MYOK
18
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$83.3M 1.84%
1,601,307
+63,176
+4% +$2.91M
GDDY icon
19
GoDaddy
GDDY
$11.8B
$80.8M 1.79%
1,074,417
-1,136,391
-51% -$79.9M
BOLD
20
DELISTED
Audentes Therapeutics, Inc
BOLD
$79.2M 1.75%
2,030,481
-990,778
-33% -$28.4M
XNTK icon
21
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.14B
$79.1M 1.75%
+2,666,000
New +$178M
BPMC
22
DELISTED
Blueprint Medicines
BPMC
$77.2M 1.71%
964,075
-506,361
-34% -$37.4M
TMO icon
23
Thermo Fisher Scientific
TMO
$196B
$77M 1.7%
281,436
+19,329
+7% +$4.81M
MOH icon
24
Molina Healthcare
MOH
$11.6B
$71.1M 1.57%
500,538
+151,379
+43% +$20.5M
EW icon
25
Edwards Lifesciences
EW
$48.6B
$68.9M 1.52%
1,080,921
-541,560
-33% -$30.9M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q1 2019 Portfolio in Review

As of Q1 2019, PFM Health Sciences held 126 positions worth $4.52B, up 20% from $3.76B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

PFM Health Sciences deployed $251M of net new capital in Q1 2019, opening 33 new positions and adding to 18 existing holdings. Its largest new stake was Stryker: 579,444 shares worth $114M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 51% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Spark Therapeutics, Inc. Common Stock, an estimated $145M trimmed.

  • PFM Health Sciences's largest Q1 2019 buy was Stryker: 579,444 shares worth $114M.
  • PFM Health Sciences added most to Pfizer in Q1 2019, an estimated $80.2M increase.
  • PFM Health Sciences's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $145M.
  • PFM Health Sciences fully exited Abbott in Q1 2019, selling an estimated $82.8M.
  • PFM Health Sciences's ten largest holdings make up 33% of its $4.52B portfolio in Q1 2019.
  • PFM Health Sciences opened 33 new positions and closed 36 in Q1 2019.
  • PFM Health Sciences's portfolio value rose 20% quarter-over-quarter to $4.52B.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.